BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8620126)

  • 1. Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994.
    Giles GG; Armstrong BK; Burton RC; Staples MP; Thursfield VJ
    BMJ; 1996 May; 312(7039):1121-5. PubMed ID: 8620126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of age, birth cohort and period of death on skin melanoma mortality in Spain, 1975 through 2004.
    Cayuela A; Rodríguez-Domínguez S; Vigil E; Conejo-Mir JS
    Int J Cancer; 2008 Feb; 122(4):905-8. PubMed ID: 17957799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of trends in mortality from malignant melanoma of the skin in Australia.
    Holman CD; James IR; Gattey PH; Armstrong BK
    Int J Cancer; 1980 Dec; 26(6):703-9. PubMed ID: 7216539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in mortality from cutaneous malignant melanoma in Spain (1982-2016): sex-specific age-cohort-period effects.
    Gutiérrez-González E; López-Abente G; Aragonés N; Pollán M; Pastor-Barriuso R; Sánchez MJ; Pérez-Gómez B
    J Eur Acad Dermatol Venereol; 2019 Aug; 33(8):1522-1528. PubMed ID: 30868690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in melanoma mortality in Australia: 1950-2002 and their implications for melanoma control.
    Baade P; Coory M
    Aust N Z J Public Health; 2005 Aug; 29(4):383-6. PubMed ID: 16222938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of trends in melanoma mortality in New Zealand and Australia: the two countries with the highest melanoma incidence and mortality in the world.
    Sneyd MJ; Cox B
    BMC Cancer; 2013 Aug; 13():372. PubMed ID: 23915380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Has mortality from malignant melanoma stopped rising in Spain? Analysis of trends between 1975 and 2001.
    Cayuela A; Rodríguez-Domínguez S; Lapetra-Peralta J; Conejo-Mir JS
    Br J Dermatol; 2005 May; 152(5):997-1000. PubMed ID: 15888159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group.
    MacKie RM; Hole D; Hunter JA; Rankin R; Evans A; McLaren K; Fallowfield M; Hutcheon A; Morris A
    BMJ; 1997 Nov; 315(7116):1117-21. PubMed ID: 9374883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interstate differences in incidence and mortality from melanoma. A re-examination of the latitudinal gradient.
    Jones ME; Shugg D; Dwyer T; Young B; Bonett A
    Med J Aust; 1992 Sep; 157(6):373-8. PubMed ID: 1447984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous melanoma.
    Armstrong BK; Kricker A
    Cancer Surv; 1994; 19-20():219-40. PubMed ID: 7534627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generational shift in melanoma incidence and mortality in Queensland, Australia, 1995-2014.
    Aitken JF; Youlden DR; Baade PD; Soyer HP; Green AC; Smithers BM
    Int J Cancer; 2018 Apr; 142(8):1528-1535. PubMed ID: 29105744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia.
    de Vries E; Bray FI; Coebergh JW; Parkin DM
    Int J Cancer; 2003 Oct; 107(1):119-26. PubMed ID: 12925966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in mortality from cutaneous malignant melanoma in Belgium.
    Bleyen L; De Bacquer D; Myny K; Brochez L; Naeyaert JM; De Backer G
    Int J Epidemiol; 1999 Feb; 28(1):40-5. PubMed ID: 10195662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing trends in the epidemiology of malignant melanoma: gender differences and their implications for public health.
    Streetly A; Markowe H
    Int J Epidemiol; 1995 Oct; 24(5):897-907. PubMed ID: 8557445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983-1996.
    Marrett LD; Nguyen HL; Armstrong BK
    Int J Cancer; 2001 May; 92(3):457-62. PubMed ID: 11291086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent declines in worldwide mortality from cutaneous melanoma in youth and middle age.
    La Vecchia C; Lucchini F; Negri E; Levi F
    Int J Cancer; 1999 Mar; 81(1):62-6. PubMed ID: 10077154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality from cutaneous melanoma: evidence for contrasting trends between populations.
    Severi G; Giles GG; Robertson C; Boyle P; Autier P
    Br J Cancer; 2000 Jun; 82(11):1887-91. PubMed ID: 10839308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous malignant melanoma in New Zealand: trends by anatomical site, 1969-1993.
    Bulliard JL; Cox B
    Int J Epidemiol; 2000 Jun; 29(3):416-23. PubMed ID: 10869312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany.
    Stang A; Jöckel KH
    Cancer; 2016 Feb; 122(3):432-7. PubMed ID: 26480048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma mortality in Brazil: trends and projections (1998-2032).
    Santos CAD; Souza DLB
    Cien Saude Colet; 2019 Apr; 24(4):1551-1561. PubMed ID: 31066856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.